Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

Comprehensive study exposes critical health risks of obesity, including diabetes, heart disease, and cancer, while offering hope through clinical trials.

The new classification system divides obesity into two distinct stages. Stage 1 is “innocuous obesity," which is characterised by increased body fat without any organ or metabolic dysfunction while ...

Amgen Inc. sees the potential for 2025 revenues to top Wall Street estimates thanks to growth in cholesterol and cancer drugs ...

Amgen’s mysterious obesity asset will remain a mystery for a bit longer—the FDA has put the candidate’s phase 1 trial on a clinical hold, the company announced Feb. 4. Amgen has not detailed ...